These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 20206130

  • 1. Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes.
    Kishi M, Yasuda H, Abe Y, Sasaki H, Shimizu M, Arai T, Okumachi Y, Moriyama H, Hara K, Yokono K, Nagata M.
    Biochem Biophys Res Commun; 2010 Mar 26; 394(1):228-32. PubMed ID: 20206130
    [Abstract] [Full Text] [Related]

  • 2. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP.
    Diabetes; 2009 Jan 26; 58(1):146-55. PubMed ID: 18984738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
    Li A, Ojogho O, Franco E, Baron P, Iwaki Y, Escher A.
    Vaccine; 2006 Jun 05; 24(23):5036-46. PubMed ID: 16621191
    [Abstract] [Full Text] [Related]

  • 7. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.
    J Clin Invest; 1998 Aug 01; 102(3):499-506. PubMed ID: 9691086
    [Abstract] [Full Text] [Related]

  • 8. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P.
    Novartis Found Symp; 2008 Aug 01; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [Abstract] [Full Text] [Related]

  • 9. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M, Piccirillo CA.
    J Leukoc Biol; 2007 Aug 01; 82(2):335-46. PubMed ID: 17475784
    [Abstract] [Full Text] [Related]

  • 10. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L.
    Proc Natl Acad Sci U S A; 2007 Apr 10; 104(15):6335-40. PubMed ID: 17389382
    [Abstract] [Full Text] [Related]

  • 11. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM.
    J Exp Med; 2003 Dec 15; 198(12):1875-86. PubMed ID: 14676299
    [Abstract] [Full Text] [Related]

  • 12. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes.
    Han B, Serra P, Yamanouchi J, Amrani A, Elliott JF, Dickie P, Dilorenzo TP, Santamaria P.
    J Clin Invest; 2005 Jul 15; 115(7):1879-87. PubMed ID: 15937548
    [Abstract] [Full Text] [Related]

  • 13. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
    Kapp JA, Honjo K, Kapp LM, Xu Xy, Cozier A, Bucy RP.
    Int Immunol; 2006 Nov 15; 18(11):1549-62. PubMed ID: 16966495
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes.
    Wang R, Song L, Han G, Wang J, Chen G, Xu R, Yu M, Qian J, Shen B, Li Y.
    Scand J Immunol; 2007 Nov 15; 66(5):515-22. PubMed ID: 17883389
    [Abstract] [Full Text] [Related]

  • 15. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
    Sun JB, Cuburu N, Blomquist M, Li BL, Czerkinsky C, Holmgren J.
    Scand J Immunol; 2006 Sep 15; 64(3):251-9. PubMed ID: 16918694
    [Abstract] [Full Text] [Related]

  • 16. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
    Song L, Wang J, Wang R, Yu M, Sun Y, Han G, Li Y, Qian J, Scott DW, Kang Y, Soukhareva N, Shen B.
    Gene Ther; 2004 Oct 15; 11(20):1487-96. PubMed ID: 15343360
    [Abstract] [Full Text] [Related]

  • 17. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W.
    Immunol Lett; 2009 Aug 15; 125(2):105-13. PubMed ID: 19539651
    [Abstract] [Full Text] [Related]

  • 18. Regulatory CD4+ T cells redirected against pathogenic CD8+ T cells protect NOD mice from development of autoimmune diabetes.
    Kakabadse D, Chen D, Fishman S, Weinstein-Marom H, Davies J, Wen L, Gross G, Wong FS.
    Front Immunol; 2024 Aug 15; 15():1463971. PubMed ID: 39351219
    [Abstract] [Full Text] [Related]

  • 19. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
    Unger WW, Pinkse GG, Mulder-van der Kracht S, van der Slik AR, Kester MG, Ossendorp F, Drijfhout JW, Serreze DV, Roep BO.
    Ann N Y Acad Sci; 2007 Apr 15; 1103():192-5. PubMed ID: 17376840
    [Abstract] [Full Text] [Related]

  • 20. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
    Martinuzzi E, Novelli G, Scotto M, Blancou P, Bach JM, Chaillous L, Bruno G, Chatenoud L, van Endert P, Mallone R.
    Diabetes; 2008 May 15; 57(5):1312-20. PubMed ID: 18305140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.